Literature DB >> 19194961

Association study of CREB1 with Major Depressive Disorder and related phenotypes.

John M Hettema1, Seon-Sook An, Edwin J C G van den Oord, Michael C Neale, Kenneth S Kendler, Xiangning Chen.   

Abstract

Cyclic AMP response element binding protein (CREB) has been implicated in behavioral models of anxiety and depression, antidepressant response in humans, and suicide. One group reported a female-specific association of the CREB1 gene in early-onset Major Depressive Disorder (MDD), while another found no evidence of association with this phenotype. In this study, we sought to examine the evidence for association of the CREB1 gene to MDD and related phenotypes. We used multivariate structural equation modeling to identify and select twin pairs that scored at the extremes of a latent genetic risk factor shared by MDD, neuroticism, and several anxiety disorders from the Virginia Twin Registry. Using one member from each of these pairs, the resulting sample of 589 cases (including 473 subjects with lifetime MDD) and 539 controls were entered into a 2-stage association study in which genetic markers were screened in stage 1, the positive results of which were tested for replication in stage 2. Eight SNP markers selected to capture the major allelic variation across the haplotype block containing CREB1 were analyzed for differences between cases and controls. Several markers showed criterion differences between cases and controls in the stage 1 sample with some evidence of sex specific effects. However, none of these markers were significant in stage 2 in either sex individually or combined. Our data suggests that common variations in the CREB1 gene do not appear to increase susceptibility for MDD or related phenotypes. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19194961      PMCID: PMC2844886          DOI: 10.1002/ajmg.b.30935

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  30 in total

1.  Allelic discrimination using fluorogenic probes and the 5' nuclease assay.

Authors:  K J Livak
Journal:  Genet Anal       Date:  1999-02

2.  Susceptibility genes for nicotine dependence: a genome scan and followup in an independent sample suggest that regions on chromosomes 2, 4, 10, 16, 17 and 18 merit further study.

Authors:  R E Straub; P F Sullivan; Y Ma; M V Myakishev; C Harris-Kerr; B Wormley; B Kadambi; H Sadek; M A Silverman; B T Webb; M C Neale; C M Bulik; P R Joyce; K S Kendler
Journal:  Mol Psychiatry       Date:  1999-03       Impact factor: 15.992

3.  The International HapMap Project.

Authors: 
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

4.  lga972: a cross-platform application for optimizing LD studies using a genetic algorithm.

Authors:  Jaime R Robles; Edwin J C G van den Oord
Journal:  Bioinformatics       Date:  2004-06-04       Impact factor: 6.937

5.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

6.  A population-based twin study of lifetime major depression in men and women.

Authors:  K S Kendler; C A Prescott
Journal:  Arch Gen Psychiatry       Date:  1999-01

Review 7.  The co-morbidity of anxiety and depression in the perspective of genetic epidemiology. A review of twin and family studies.

Authors:  C M Middeldorp; D C Cath; R Van Dyck; D I Boomsma
Journal:  Psychol Med       Date:  2005-05       Impact factor: 7.723

8.  Effects of cyclic adenosine monophosphate response element binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety.

Authors:  Tanya L Wallace; Kathryn E Stellitano; Rachael L Neve; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2004-08-01       Impact factor: 13.382

9.  Expression of cAMP response element-binding protein in major depression before and after antidepressant treatment.

Authors:  I-Ching Lai; Chen-Jee Hong; Shih-Jen Tsai
Journal:  Neuropsychobiology       Date:  2003       Impact factor: 2.328

10.  Genetic covariation between neuroticism and the symptoms of anxiety and depression.

Authors:  R Jardine; N G Martin; A S Henderson
Journal:  Genet Epidemiol       Date:  1984       Impact factor: 2.135

View more
  5 in total

1.  CREB1 gene polymorphisms combined with environmental risk factors increase susceptibility to major depressive disorder (MDD).

Authors:  Peng Wang; Yanjie Yang; Xiuxian Yang; Xiaohui Qiu; Zhengxue Qiao; Lin Wang; Xiongzhao Zhu; Hong Sui; Jingsong Ma
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

2.  Genetic and clinical determinants of mizoribine pharmacokinetics in renal transplant recipients.

Authors:  Rui Dai; Jingjie Li; Jingjing Wu; Qian Fu; Jiajia Yan; Guoping Zhong; Changxi Wang; Xiao Chen; Pan Chen
Journal:  Eur J Clin Pharmacol       Date:  2020-08-15       Impact factor: 2.953

3.  Pharmacogenetics of antidepressants.

Authors:  Concetta Crisafulli; Chiara Fabbri; Stefano Porcelli; Antonio Drago; Edoardo Spina; Diana De Ronchi; Alessandro Serretti
Journal:  Front Pharmacol       Date:  2011-02-16       Impact factor: 5.810

4.  A comprehensive network and pathway analysis of candidate genes in major depressive disorder.

Authors:  Peilin Jia; Chung-Feng Kao; Po-Hsiu Kuo; Zhongming Zhao
Journal:  BMC Syst Biol       Date:  2011-12-23

5.  GNB3 and CREB1 gene polymorphisms combined with negative life events increase susceptibility to major depression in a Chinese Han population.

Authors:  Jingsong Ma; Lin Wang; Yanjie Yang; Zhengxue Qiao; Deyu Fang; Xiaohui Qiu; Xiuxian Yang; Xiongzhao Zhu; Jincai He; Hui Pan; Bo Ban; Yan Zhao; Hong Sui
Journal:  PLoS One       Date:  2017-02-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.